Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Startek Reports First Quarter 2022 Financial Results: https://mms.businesswire.com/media/20210317005065/en/865538/5/STARTEK_logo.jpg
Startek Reports First Quarter 2022 Financial Results


Startek, Inc. (NYSE:SRT) ("Startek" or the "Company"), a global customer experience (CX) solutions provider, is reporting financial results for the first quarter ended March 31, 2022.



First

Trex Company Reports Record Results for First Quarter 2022: https://mms.businesswire.com/media/20200121005014/en/553939/5/TREX0406_Logo_Resize_L1rd_10_2016.jpg
Trex Company Reports Record Results for First Quarter 2022


Trex Company, Inc. (NYSE:TREX), the world’s #1 brand of high-performance, low-maintenance and eco-friendly composite decking, railing and outdoor living products and a leading national provider of

Intevac Announces First Quarter 2022 Financial Results: https://mms.businesswire.com/media/20191101005110/en/497226/5/IVAC_LOGO_Horizontal_.jpg
Intevac Announces First Quarter 2022 Financial Results


Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the first quarter ended April 2, 2022.



Q1 Highlights:




  • Achieved new 12-year record high in quarterly bookings and backlog for

Origin Materials, Inc. Reports Financial Results for First Quarter 2022: https://mms.businesswire.com/media/20211201005247/en/931722/5/Logo_New.jpg
Origin Materials, Inc. Reports Financial Results for First Quarter 2022


Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to enable the world’s transition

MedinCell: US Pharma Development Expert Richard Malamut, MD Becomes Chief Medical Officer: https://mms.businesswire.com/media/20191128005494/en/700687/5/MedinCell-Logo-notagline.jpg
MedinCell: US Pharma Development Expert Richard Malamut, MD Becomes Chief Medical Officer


"After working as an active member of the Medical Advisory Board of MedinCell, I am delighted to be joining full time the company as a CMO at a time when its first product is in the final stage of

Philip Morris International Inc. Confirms Discussions With Swedish Match AB Regarding Potential Offer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23874/225px-Philip_Morris_International_Logo.svg.png
Philip Morris International Inc. Confirms Discussions With Swedish Match AB Regarding Potential Offer


Philip Morris International Inc. (PMI) (NYSE: PM) today confirmed, in response to recent market speculation, that discussions are ongoing between PMI and Swedish Match AB (STO: SWMA) regarding a

ACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022: https://mms.businesswire.com/media/20220330005534/en/1304115/5/Acticor_Biotech.jpg
ACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022


Regulatory News:



ACTICOR BIOTECH (ISIN : FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, announces

Discover Financial Services Announces 2022 Annual Meeting of Shareholders: https://mms.businesswire.com/media/20191118005067/en/756953/5/Discover_NHL_092019v2_lock_up_2020.jpg
Discover Financial Services Announces 2022 Annual Meeting of Shareholders


Discover Financial Services (NYSE: DFS) plans to host its 2022 Annual Meeting of Shareholders entirely online on Thursday, May 19, 2022, at 9:00 a.m. Central time. All shareholders of record of our

DGAP-News: Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
DGAP-News: Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
DGAP-News: Disclosure on share buy-back according to Article 2 (1) of the Delegated Regulation (EU) No. 2016/1052 and Article 5 (1) Regulation (EU) No 2014/596 (Market Abuse Regulation)
DGAP-Adhoc: Corestate Capital Holding S.A.: Evaluation of options for refinancing, including potential alternative scenarios. Financial outlook for 2022 is withdrawn.
DGAP-Adhoc: Corestate Capital Holding S.A.: Evaluation of options for refinancing, including potential alternative scenarios. Financial outlook for 2022 is withdrawn.
DGAP-Adhoc: Corestate Capital Holding S.A.: Evaluation of options for refinancing, including potential alternative scenarios. Financial outlook for 2022 is withdrawn.
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Cloudflare Teams Up With Open Source Community to Create New API Standards for the Applications of the Future: https://mms.businesswire.com/media/20200719005029/en/738100/5/cf-logo-h-rgb.jpg
Cloudflare Teams Up With Open Source Community to Create New API Standards for the Applications of the Future


Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced that it is collaborating with Deno and individual core

Wrike Enters Agreement With Operator of the World’s Largest Ecosystem of Cloud Solutions, Ingram Micro Cloud: https://mms.businesswire.com/media/20191101005123/en/196157/5/Citrix_logo.jpg
Wrike Enters Agreement With Operator of the World’s Largest Ecosystem of Cloud Solutions, Ingram Micro Cloud


Wrike, the most powerful work management platform, now part of Citrix, today announced a new agreement with Ingram Micro Cloud that positions Wrike as its newest collaborative work management (CWM)

Guidewire Wins Three Celent XCelent Awards, Named a Luminary for Claims Management: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire Wins Three Celent XCelent Awards, Named a Luminary for Claims Management


Guidewire (NYSE: GWRE) announced that ClaimCenter has been named a winner of all three XCelent awards in Celent’s Claims Systems Vendors: North American Property Casualty Insurance, 2022 Edition re

Echelon Insurance Deploys Guidewire InsuranceSuite to Transform Core Operations: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Echelon Insurance Deploys Guidewire InsuranceSuite to Transform Core Operations


Echelon Insurance (Echelon), a leading Canadian Specialty insurer, and Guidewire (NYSE: GWRE) announced that Echelon has successfully deployed InsuranceSuite and DataHub as its new underwriting

Exelon Reports First Quarter 2022 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png
Exelon Reports First Quarter 2022 Results


Exelon Corporation (Nasdaq: EXC) today reported its financial results for the first quarter of 2022.



“The first quarter was a milestone for Exelon as we successfully completed our separation of

DGAP-Adhoc: Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
DGAP-Adhoc: Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
DGAP-Adhoc: Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
DGAP-Adhoc: Fabasoft AG: Disclosure of an inside information according to Article 17 MAR
DGAP-Adhoc: Fabasoft AG: Disclosure of an inside information according to Article 17 MAR
DGAP-Adhoc: Fabasoft AG: Disclosure of an inside information according to Article 17 MAR
Fifth Third Sets New Operational Sustainability Targets by 2030 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24455/Fifth_Third_Bank.svg_%281%29.png
Fifth Third Sets New Operational Sustainability Targets by 2030


Fifth Third today announced six new operational sustainability targets to be achieved by 2030. These targets build upon the Bank’s initial five goals set in 2017, which established the foundation

UiPath Launches Next-Gen UiPath Automation Cloud™ to Extend Automation Leadership in Latest Platform Release: https://mms.businesswire.com/media/20210427005075/en/718791/5/new_uipath_logo_orange.jpg
UiPath Launches Next-Gen UiPath Automation Cloud™ to Extend Automation Leadership in Latest Platform Release


UiPath (NYSE: PATH), a leading enterprise automation software company, today introduced Automation Cloud Robots alongside a wealth of other powerful new capabilities as a part of the UiPath 2022.4

The L.S. Starrett Company Announces Fiscal 2022 Third Quarter Results: https://mms.businesswire.com/media/20220509005035/en/1445580/5/Starrett_Logo_from_June_2008_CIM_2in.jpg
The L.S. Starrett Company Announces Fiscal 2022 Third Quarter Results


The L.S. Starrett Company (NYSE: SCX) (“Starrett” or “the Company”) a global innovator, manufacturer and marketer of precision measuring tools, cutting tools and equipment, and high-end metrology

Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans


Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ)

IPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg
IPA’s Subsidiary BioStrand Secures Second VLAIO Research Grant


Diepe IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to share that IPA’s subsidiary Biostrand, a Belgian end-to-end multi-omics analysis platform

Elys Game Technology Enters into Virtual Sports Retail Distribution Agreements: https://mms.businesswire.com/media/20200617005433/en/779190/5/NewGiocoGroup-logo-Png-Black.jpg
Elys Game Technology Enters into Virtual Sports Retail Distribution Agreements


Elys Game Technology, Corp. (“Elys" or the “Company") (Nasdaq:ELYS)(BER:3UW), an interactive gaming and sports betting technology company, announced today that the Company has entered into retail